health
Ultra-low doses could bring costly cancer treatments to more patients in poorer countries
Why this matters: health reporting relevant to everyday decisions and well-being.
Low-dose, low-cost immunotherapies may help patients in poorer countries access high-tech cancer treatments.
Read full story on STAT News → More top storiesAlso covered by
Aggregated and edited by the Scoop newsroom. We surface news from STAT News alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop